Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Open Label, Multi-Center, Single and Multiple Dose, Dose Escalation and Expansion Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S in Previously Treated Patients With Advanced or Metastatic Cancers With High LAT1 Signatures, and in Patients With Relapsed or Refractory Grade 4 Astrocytoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04430842
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:50.067061+00:00
Published At
2023-01-18T00:00:00+00:00
Record Updated At
2023-01-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Astrocytoma", "Brain Cancer", "Brain Metastases", "Bladder Cancer", "Breast Cancer", "Cervical Cancer", "Cholangiocarcinoma", "Colorectal Cancer", "Esophagus Cancer", "Gastric Cancer", "Head and Neck Cancer", "Kidney Cancer", "Liver Cancer", "Lung Cancer", "Melanoma", "Ovarian Cancer", "Pancreatic Cancer", "Pleural Mesothelioma", "Prostate Cancer", "Sarcoma", "Tongue Cancer", "Thymic Carcinoma", "Urinary Tract Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-01-18"
protocolSection.identificationModule.nctId
"NCT04430842"
protocolSection.identificationModule.officialTitle
"A Phase 1, Open Label, Multi-Center, Single and Multiple Dose, Dose Escalation and Expansion Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S in Previously Treated Patients With Advanced or Metastatic Cancers With High LAT1 Signatures, and in Patients With Relapsed or Refractory Grade 4 Astrocytoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Astrocytoma (protocolSection.conditionsModule.conditions)
  • Brain Cancer (protocolSection.conditionsModule.conditions)
  • Brain Metastases (protocolSection.conditionsModule.conditions)
  • Bladder Cancer (protocolSection.conditionsModule.conditions)
  • Breast Cancer (protocolSection.conditionsModule.conditions)
  • Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Colorectal Cancer (protocolSection.conditionsModule.conditions)
  • Esophagus Cancer (protocolSection.conditionsModule.conditions)
  • Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Head and Neck Cancer (protocolSection.conditionsModule.conditions)
  • Kidney Cancer (protocolSection.conditionsModule.conditions)
  • Liver Cancer (protocolSection.conditionsModule.conditions)
  • Lung Cancer (protocolSection.conditionsModule.conditions)
  • Melanoma (protocolSection.conditionsModule.conditions)
  • Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Pleural Mesothelioma (protocolSection.conditionsModule.conditions)
  • Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Sarcoma (protocolSection.conditionsModule.conditions)
  • Tongue Cancer (protocolSection.conditionsModule.conditions)
  • Thymic Carcinoma (protocolSection.conditionsModule.conditions)
  • Urinary Tract Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.